ABSTRACT:"To discover chemical probes to ' I Hit" r 0 anmes,<; ass I e as an exce en rug scau?, ,,:' were loun
I Hit"
r 0 anmes,<; ass I e as an exce en rug scau?, ,,:' were loun
to b,e the mo, st potent inhibitors for DNA Pol A ,' , ' Importantly, \..( N~ ~>-r they are up to 10 times less active against the, highly similar s~ 0 DNA polymerase (3. We investigated basic st~cture activity relationships. Furthermore, the rhodanines showed pharmacological activity in two human cancer cell lines. So the here reported small molecules could serve as useful DNA Pol~ probes and might serve as starting point to develop novel therapeutic agents.
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-, E ach organism is affected by DNA damaging agents, To maintain the genetic integrity of its genome, sophisticated repair systems have evolved. Errors in this process can lead to severe developmental defects and cancer. Key enzymes for the maintenance of the integrity of the genome are DNA poly merases involved in the DNA synthesis, repair of DNA lesions, and recombination. I 4 In humans 15 DNA polymerases are known. 4 The entire process of DNA replication takes minutes, and individual steps take place in split seconds. s Given their fast mode of action, cell permeable small molecules are ideally suited to interfere in this highly dynamic process. However, to under stand in depth the function of individual DNA polymerases, appropriate small molecule inhibitors are required, These mole cules might not only be of great value for basic research but may also open up novel avenues for the treatment of diseases related to genome integrity. 6 8 In this work, we focused on the recently described human DNA polymerase A-(DNA Pol A-), a member of the DNA polymerase X family.9 The exonuclease deficient DNA Pol A contains all the critical residues involved in DNA binding, nucleotide binding and selection, and catalysis of DNA poly merization that are conserved in DNA polymerase (3 (DNA Pol (3), Thus, the sequence and the three dimensional structure of the catalytic core in the C terminal part of DNA Pol A (residues 244 -575) are highly similar to DNA Pol (3 (Figure lA, B A recent investigation of the expression patterns of specialized DNA polymerases in 68 different tumor samples revealed that in more than 45% of these tumors at least one specialized DNA polymerase was 2 fold enhanced expressed. Of particular interest was the fact that over 30% of all samples had either DNA Pol Aor (3 overexpressed?4 Consequently, both DNA polymerases are discussed as promising new drug targets for the treatment of cancer. 2 4,25 One goal for targeting these DNA polymerases is the inhibition of the repair of DNA adducts caused by DNA damaging anticancer agents. To the best of our knowledge, known inhibitors of the polymerase function of DNA Pol A-are exclusively based on natural products,3 and the strongest known inhibitor is (-) epigallocatechin gallate (EGCG) isolated from green tea reported with a half maximal inhibitory concentration (IC so ) value of 3.8 I1M? 6 To identify inhibitors of DNA polymerases, we adapted our recently described SYBR Green based assal 7 ,28 for inhibitor high throughput screening (HTS) ( Figure IC Compounds were considered as "hits" if the relative fluorescence was significantly lower than the positive control (Supporting Information). It should be mentioned that the identified collec tion of hits might not be complete since additional active compounds might have been missed during screening. The identified 159 hits were additionally studied with a more sensi tive method. Therefore, PEX with a shorter 33 nucleotide tem plate and radioactive labeled primer with the same sequence context were used. In this way we could identify 11 highly ac tive compounds out of the 159 hits. On the basis of the structures, the 11 hits can be subdivided in three inhibitor classes: Class I are rhodanines (5 arylidene 2,4 thiazolidinediones), class II has members of carbohydrazides, and class III contains a common 2,4 pentadione substructure element ( Figure 2Aj Supplementary IC so of 64.4 ftM and could hence discriminate between the two highly similar family X DNA polymerases with a factor of ~ 10 ( Figure 2B ,C). To further evaluate compound I, we used EGCG in a side by side comparison using the radioactive PEX assay. We found that EGCG is less active as 1 in this assay ( Figure 2D , Supplementary  Figure 52 ), and thus 1 was selected as lead for further investigations.
To investigate if 1 competes with the natural dNTP substrates, we conducted a PEX assay in the presence of a given amount of inhibitor and increasing concentrations of dNTPs ( Figure 2E ). The abse nce of reaction products even in the presence of increasing amounts of dNTP indicates that 1 inhibits DNA Pol A without directly competing for the same binding site. 315 It was reported that human DNA Pol A has a TDT activity, and its involvement in recombination events was suggested.
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, 33 Thus, to test the inhibitory potential of I, we investigated TDT activity using a radioactive assay of Single stranded primer extension ( Figure 2F ,G) similar to what has been described before. 34 We found that 1 inhibits dose dependently the TDT function of DNA Pol A with an IC so value of 4.5 ftM.
To establish basic structure-activity relationships (SAR), we subdivided 1 in a molecular scaffold. The scaffold consists of three variable parts, Rl, R2, and R 3 , which are connected via a phenyl ring and a variable linkage Z, respectively (Table 1 ). Next, we tested scaffold oriented small molecules 12-35 (Table I , Supporting Information) at 20 ftM concentration in the radio active DNA Pol A PEX assay (Table I, Supplementary Figure   53 ). To identify the core inhibitory structure, the compounds 12-16 were made accessible. These compounds are less active. By comparing the analogues 1,3,4, and 17-21, we noticed that molecules tend to higher activity with the linkage Z in the position para to the rhodanine moiety A. However, compounds 4 and 21 with 4 chlorophenyl substituents in R3 do not follow this trend. The 4 methylphenyl substituent (R3) in 1 also seems to have influence on the activity, because by its substitution with 4 chlorophenyl (21) or 4 bromophenyl (22), the analogues lost activity. The same effect was observed for 18 and 23, because the substitution of the trifluoromethyl group in R3 (18) All of these data indicate that th e rhodanine moiety A is very important for a highly active inhibitor. Next, we tested small molecules that had an inhibitory activity against DNA Pol A in the PEX assay of at least 90% for their effect on DNA Pol {3. For these DNA Pol {3 PEX assays compounds were used at SO tIM. (Table 1 , Supplementary Figure S4) . Interestingly, by modifying position R 2 and R3 of the scaffold, we generated the active but unselective compo unds 19, 20, and 28. These findings suggest that the rodanines act in the C terminal part 316 of DNA Pol A, as this part is highly conserved in both DNA polymerases (Figure lA, B) . Compounds 18,24,29, and 31 are still able to discriminate between the two DNA polymerases, and thus the IC so values for DNA Pol A and {3 were also investigated (Table 1 , Supporting Information). In general, rhodanines are classified as nonmutagenic,3S and a long term study on the clinical effects of the rhodanine based Epalrestat demonstrated that it is well tolerated by patients. 36
Given that DNA Pol A is discussed as a promising cellular target, especially in the case of cancer treatment,2 4 we determined the half maximal inhibitory concentration of the cell viability (EC so ) of the discovered rhodanines 1, 18, 24, 29, and 31 using two human cancer cell lines, a cervix carcinoma cell line, HeLa S3, and a hepatocellular carcinoma cell line, Hep G2 (Figure 3) . In both of these cancer types DNA Pol A is overexpressed. other compounds affected the viability of these cell lines at concentrations 2 to 5 fold higher than the IC so values of DNA Pol A. (Table 1 ). These results suggest that 1,24,29, and 31 are appropriate small molecul e probes.
In conclusion, we established a new generally applicable HTS for small molecule inhibitors of DNA polymerases. With the aid of this m ethod and a radioactive PEX assay, we discovered three novel inhibitor classes of the DNA poly me rase function of the human DNA Pol A.: the rhodanines, the carbohydrazides, and compounds with a common 2,4 pentadione substructure. The rhodanines were the most potent inhibitors and were able to discriminate with a factor 5 to 10 b etween the DNA Pol A. and f3. The structure of the most potent molecule 1 (IC so = 5.9 ,uM) was confirmed via resynthes is. We inves tigated some basic SAR and thereby we discovered other inhibitors whose properties are comparable with 1. We compared these compounds with the most active known inhibitor EGCG and found that the herein reported rhodanin es are currently the strongest inhibitors for DNA 
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